跳至主要内容
临床试验/DRKS00007781
DRKS00007781已完成未知

Effect of dietary lipid modification on nonalcoholic fatty liver disease in carriers of the PNPLA3 I148M genetic variant: an open label trial

Saarland University Medical Center0 个研究点目标入组 20 人开始时间: 2015年3月25日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
N/a: Single Arm Study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • 1. Patients with non-alcoholic fatty liver disease
  • 2. Patients with the PNPLA3-Genotype (p.148MM and p.I148II)

排除标准

  • Known infection with viral hepatitis, HIV or cholestatic liver diseases (e.g. PBC, PSC).
  • Presence of Diabetes Mellitus Type 2 (HbA1c = 7.5% (= 58 mmol/mol)
  • Presence of Alcoholic Fatty Liver Disease
  • with a weekly alcohol consumption of > 21 drinks (> 30 g alcohol/Day) in men and >14 drinks (> 20 g alcohol/Day) in women (2)
  • Presence of liver cirrhosis based on liver stiffness measurement (transient elastography = 13kPa FibroScan®,Echosens, Paris, France)
  • Medications known to increase fatty liver (e.g. Amiodarone, Methotrexat) or to affect carbohydrate or lipid metabolism?
  • Vegetarians or vegans

研究者

发起方
Saarland University Medical Center

相似试验

Effect of dietary lipid modification on nonalcoholic... | 临床试验